Predictive significance of Charcot-Leyden crystal structures for nasal polyp recurrence

被引:12
|
作者
Chen, Wenyi [1 ]
Bai, Yurong [1 ]
Kong, Weifeng [1 ]
Luo, Xin [1 ]
Zeng, Yinhui [2 ]
Chen, Jingyuan [1 ]
Wang, Xinyue [1 ]
Wu, Qingwu [1 ]
Chaudhuri, Shuvam [3 ]
Chen, Jianning [4 ]
Yang, Qintai [1 ,5 ]
Zhang, Yana [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Otolaryngol Head & Neck Surg, 600 Tianhe Rd, Guangzhou 510630, Peoples R China
[2] Guangzhou Women & Childrens Med Ctr, Dept Otolaryngol Head & Neck Surg, Guangzhou, Peoples R China
[3] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL USA
[4] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Allergy, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1002/clt2.12212
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Charcot-Leyden crystals (CLCs) are recognized to be classic hallmarks of eosinophilic inflammation. Both protein and mRNA levels of CLC in nasal secretions and nasal brushing samples have been associated with nasal polyp recurrence. However, whether the crystalline CLC structures in nasal tissue could serve as an effective biomarker to predict polyp recurrence remains unclear. Methods: A total of 110 patients with chronic rhinosinusitis with nasal polyps (CRSwNP) completing the postoperative follow-up over a period of 24 months were recruited. Hematoxylin and eosin staining was employed for CLCs identification. The predictive factors for polyp recurrence were determined by binary logistic regression analysis. Results: Thirty three (30.00%) patients developed recurrence during a 24-month postoperative follow-up, in which 84.85% (28/33) patients had crystalline CLC structures. Logistic regression analysis showed that crystalline CLC structure in nasal tissues is predictive of polyp recurrence. Youden index demonstrated crystalline CLC structure higher than 1 per high power field can predict postoperative polyp recurrence with 84.80% sensitivity and 98.70% specificity. Conclusions: The crystalline CLC structures in nasal tissues may serve as an easy-counting and promising biomarker to predict CRSwNP recurrence.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] A Brief History of Charcot-Leyden Crystal Protein/Galectin-10 Research
    Su, Jiyong
    MOLECULES, 2018, 23 (11):
  • [22] BIOCHEMICAL-CHARACTERIZATION OF HUMAN EOSINOPHIL CHARCOT-LEYDEN CRYSTAL PROTEIN (LYSOPHOSPHOLIPASE)
    WELLER, PF
    BACH, DS
    AUSTEN, KF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (24) : 5100 - 5105
  • [23] Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population
    Lou, Hongfei
    Meng, Yifan
    Piao, Yingshi
    Wang, Chengshuo
    Zhang, Luo
    Bachert, Claus
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2015, 29 (05) : 350 - 356
  • [24] Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis Leads to Crystal Formation
    Shigeharu Ueki
    Yui Miyabe
    Yohei Yamamoto
    Mineyo Fukuchi
    Makoto Hirokawa
    Lisa A. Spencer
    Peter F. Weller
    Current Allergy and Asthma Reports, 2019, 19
  • [25] BIOSYNTHESIS OF MYRISTYLATED CHARCOT-LEYDEN CRYSTAL PROTEIN BY HL-60 CELLS
    ACKERMAN, SJ
    COBURN, EW
    WELLER, PF
    CLINICAL RESEARCH, 1986, 34 (02): : A276 - A276
  • [26] The impact of Charcot-Leyden Crystal protein on mesothelioma chemotherapy: targeting eosinophils for enhanced chemosensitivity
    Willems, Megane
    Hamaidia, Malik
    Fontaine, Alexis
    Gregoire, Melanie
    Halkin, Louise
    Mana, Lea Vilanova
    Terres, Roxane
    Jamakhani, Majeed
    Deshayes, Sophie
    Brostaux, Yves
    Heinen, Vincent
    Louis, Renaud
    Duysinx, Bernard
    Jean, Didier
    Wasielewski, Eric
    Scherpereel, Arnaud
    Blanquart, Christophe
    Willems, Luc
    EBIOMEDICINE, 2024, 109
  • [27] Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death
    Ueki, Shigeharu
    Tokunaga, Takahiro
    Melo, Rossana C. N.
    Saito, Hidekazu
    Honda, Kohei
    Fukuchi, Mineyo
    Konno, Yasunori
    Takeda, Masahide
    Yamamoto, Yohei
    Hirokawa, Makoto
    Fujieda, Shigeharu
    Spencer, Lisa A.
    Weller, Peter F.
    BLOOD, 2018, 132 (20) : 2183 - 2187
  • [28] HUMAN EOSINOPHIL CHARCOT-LEYDEN CRYSTAL PROTEIN - CLONING AND CHARACTERIZATION OF A LYSOPHOSPHOLIPASE GENE PROMOTER
    GOMOLIN, HI
    YAMAGUCHI, Y
    PAULPILLAI, AV
    DVORAK, LA
    ACKERMAN, SJ
    TENEN, DG
    BLOOD, 1993, 82 (06) : 1868 - 1874
  • [29] HUMAN EOSINOPHIL CHARCOT-LEYDEN CRYSTAL PROTEIN GENE MAPS TO HUMAN CHROMOSOME-19
    MASTRIANNI, DM
    EDDY, RL
    ROSENBERG, HF
    CORRETTE, SE
    SHOWS, TB
    TENEN, DG
    ACKERMAN, SJ
    CYTOGENETICS AND CELL GENETICS, 1991, 58 (3-4): : 2021 - 2021
  • [30] The genomic structure of the human Charcot-Leyden crystal protein gene is analogous to those of the galectin genes
    Dyer, KD
    Handen, JS
    Rosenberg, HF
    GENOMICS, 1997, 40 (02) : 217 - 221